Alprazolam
- Molecular formula
- C17H13ClN4
- CAS Number
- 28981-97-7
- IUPAC Name
- 1-(3-benzo[b][1]benzazepin-11-ylpropyl)-4-(dimethylamino)piperidine-4-carboxamide
- Molecular Weight
- 308.82g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1981g/cm3
Identification
Interesting Facts about 1-(3-benzo[b][1]benzazepin-11-ylpropyl)-4-(dimethylamino)piperidine-4-carboxamide
This compound, with a lengthy and complex name, belongs to a class of chemical compounds known as psychoactive substances. Its unique structure incorporates the benzo[b][1]benzazepine moiety, which contributes to its intriguing pharmacological profile.
Key Features:
- Diverse Applications: Compounds like this one are investigated for their potential therapeutic effects, particularly in treating neurological and psychiatric disorders.
- Sophisticated Structure: The combination of a piperidine ring and a carboxamide functional group provides versatility in chemical reactivity and interactions.
- Research Potential: It is often explored in laboratories for its ability to modulate neurotransmitter pathways, which may lead to innovative treatments.
In discussing this compound, it is essential to appreciate the challenges and excitement of synthesizing such complex molecules. As the renowned chemist Linus Pauling once said, "The best way to have a good idea is to have a lot of ideas." This notion resonates well in the field of medicinal chemistry, where the exploration of intricate structures can lead to groundbreaking discoveries.
Furthermore, the specific interactions that this compound can facilitate make it a subject of great interest in the scientific community. Ongoing studies aim to better understand its mechanism of action, metabolism, and potential benefits in clinical settings.
In summary, 1-(3-benzo[b][1]benzazepin-11-ylpropyl)-4-(dimethylamino)piperidine-4-carboxamide showcases the complexity and beauty of chemical compounds, highlighting the dynamic interplay between structure and function in the quest for new therapeutic agents.